RxDoctor Payments Data

Akbar Shakoor

Ophthalmology · Salt Lake City, UTNPI 1669675229

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $15,000 of the $17,916 with a category attached, or 83.7%. 18 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 54.6% of the total. Reporting peaked in 2022 at $9,250 and has fallen 92.7% since, to $678 in 2025. Among ophthalmology clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,916in general payments, 2019–2025

Across 49 payments — averaging $365.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$10K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$6K
  • AbbVie$502
  • Regeneron Healthcare Solutions, Inc.$305
  • Eyepoint US, Inc.$275
  • Dutch Ophthalmic, USA$255
  • plus $793 from 12 others

What the payments were for

  • Consulting fees$15,00084%
  • Speaking & faculty fees$4132%
  • Food & beverage$2,48414%
  • Gifts$190%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,916 in reported general payments places this provider in the 90th percentile of 191 ophthalmology providers in Utah.

See all ophthalmology providers in Utah

Medicare billing

Part B allowed, 2024
$958,248
Medicare patients
699
Services billed
12,902

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab13$108,567
Prednisolone Acetate62$2,994
Difluprednate11$1,484
ValacyclovirValacyclovir Hcl21$1,372
Bromfenac Sodium13$1,220
Ketorolac Tromethamine37$1,170
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat55$688
MethotrexateMethotrexate Sodium13$602
Latanoprost19$311
Brimonidine Tartrate17$128

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →